ChartMill assigns a Buy % Consensus number of 53% to ISEE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-08 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-05-04 | Baird | Downgrade | Outperform -> Neutral |
| 2023-05-03 | UBS | Downgrade | Buy -> Neutral |
| 2023-05-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-05-01 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-05-01 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-04-25 | Morgan Stanley | Maintains | Overweight |
| 2023-04-03 | Wedbush | Reiterate | Outperform |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-21 | B. Riley Securities | Maintains | Neutral |
| 2023-02-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-10 | Jefferies | Downgrade | Buy -> Hold |
| 2022-11-04 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-08 | Stifel | Maintains | Buy |
| 2022-09-07 | Guggenheim | Maintains | Buy |
| 2022-09-07 | Baird | Maintains | Outperform |
| 2022-09-06 | B. Riley Securities | Downgrade | Neutral -> Sell |
| 2022-08-02 | UBS | Initiate | Buy |
| 2022-07-07 | Morgan Stanley | Maintains | Overweight |
| 2022-06-08 | Guggenheim | Initiate | Buy |
| 2022-06-08 | B of A Securities | Initiate | Buy |
| 2022-05-12 | B. Riley Securities | Initiate | Neutral |
| 2022-03-03 | Baird | Initiate | Outperform |
| 2022-02-07 | Morgan Stanley | Initiate | Overweight |
| 2021-11-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-10 | Stifel | Initiate | Buy |
| 2021-09-10 | Credit Suisse | Maintains | Outperform |
| 2021-08-19 | HC Wainwright & Co. | Initiate | Buy |
14 analysts have analysed ISEE and the average price target is 39.88 USD. This implies a price decrease of -0.17% is expected in the next year compared to the current price of 39.95.
The consensus rating for IVERIC bio Inc (ISEE) is 52.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.